1.The Hemodynamic Performance of Carpentier-Edwards PERIMOUNT Magna for Aortic Valve Stenosis
Daisuke Takahashi ; Mitsuomi Shimamoto ; Fumio Yamazaki ; Masanao Nakai ; Yujiro Miura ; Tatsuya Itonaga ; Tatsuji Okada ; Ryota Nomura ; Noriyuki Abe ; Yasuhiko Terai
Japanese Journal of Cardiovascular Surgery 2011;40(3):81-85
This study compared the hemodynamic performance of the Carpentier-Edwards PERIMOUNT Magna bioprosthesis (Magna) with the Carpentier-Edwards PERIMOUNT bioprosthesis (CEP) for aortic valve stenosis (AS). Between January 2005 and May 2010, 164 patients underwent aortic valve replacement for AS with either the Magna (n=68) or the CEP (n=96) at our institute. Patients undergoing a concomitant mitral valve procedure were excluded from this study. The 21-mm Magna and CEP prostheses were the most frequently used during this period. Transthoracic echocardiography was postoperatively performed within 2 weeks. The peak velocity (PV) of the Magna was significantly lower than that of the CEP (2.59±0.36 vs. 2.75±0.47 m/s ; p=0.022). The mean pressure gradient (PG) was not significantly different. For the 19-mm prostheses, the mean PG and PV of the Magna were significantly lower than those of the CEP [16.4±4.5 vs. 19.7±6.4 mmHg ; p=0.034 (PG) and 2.70±0.36 vs. 3.03±0.49 m/s ; p=0.008 (PV)]. The effective orifice area (EOA) of the Magna was larger than that of the CEP [19 mm : 1.29±0.18 vs. 1.11±0.24 cm2 (p=0.007) ; 21 mm : 1.46±0.23 vs. 1.42±0.18 cm2 (p=0.370) ; and 23 mm : 1.70±0.34 vs. 1.52±0.25 cm2 (p=0.134)]. In this study, the EOA of the Magna was approximately 80% of that described in the manufacture's description. Patient-prosthesis mismatch (PPM ; EOA index≤0.85 cm2/m2) was seen in 26.8% of patients with the Magna and in 47.2% of patients with the CEP (p=0.018). Severe PPM (EOA index≤0.65 cm2/m2) was not seen in any patients with the Magna. The EOA of the 19-mm Magna was significantly larger and the mean PG was lower than those of the 19-mm CEP. Compared with the CEP, the Magna significantly reduced the incidence of PPM, and had superior hemodynamic performance.
2.Usefulness of Endoscopic Imaging to Visualize Regional Alterations in Acid Secretion of Noncancerous Gastric Mucosa after Helicobacter pylori Eradication.
Kaname UNO ; Katsunori IIJIMA ; Yasuhiko ABE ; Tomoyuki KOIKE ; Yasushi TAKAHASHI ; Nobuyuki ARA ; Tooru SHIMOSEGAWA
Journal of Gastric Cancer 2016;16(3):152-160
PURPOSE: Endoscopic diagnosis of gastric cancer (GC) that emerges after eradication of Helicobacter pylori may be affected by unique morphological changes. Using comprehensive endoscopic imaging, which can reveal biological alterations in gastric mucosa after eradication, previous studies demonstrated that Congo red chromoendoscopy (CRE) might clearly show an acid non-secretory area (ANA) with malignant potential, while autofluorescence imaging (AFI) without drug injection or dyeing may achieve early detection or prediction of GC. We aimed to determine whether AFI might be an alternative to CRE for identification of high-risk areas of gastric carcinogenesis after eradication. MATERIALS AND METHODS: We included 27 sequential patients with metachronous GC detected during endoscopic surveillance for a mean of 82.8 months after curative endoscopic resection for primary GC and eradication. After their H. pylori infection status was evaluated by clinical interviews and ¹³C-urea breath tests, the consistency in the extension of corpus atrophy (e.g., open-type or closed-type atrophy) between AFI and CRE was investigated as a primary endpoint. RESULTS: Inconsistencies in atrophic extension between AFI and CRE were observed in 6 of 27 patients, although CRE revealed all GC cases in the ANA. Interobserver and intraobserver agreements in the evaluation of atrophic extension by AFI were significantly less than those for CRE. CONCLUSIONS: We demonstrated that AFI findings might be less reliable for the evaluation of gastric mucosa with malignant potential after eradication than CRE findings. Therefore, special attention should be paid when we clinically evaluate AFI findings of background gastric mucosa after eradication (University Hospital Medical Information Network Center registration number: UMIN000020849).
Atrophy
;
Breath Tests
;
Carcinogenesis
;
Congo Red
;
Diagnosis
;
Digestive System
;
Endoscopy
;
Gastric Mucosa*
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Information Services
;
Optical Imaging
;
Stomach Neoplasms
3.The ideal focus of the study in the drug information sciences
Yasuhiko Yamada ; Yasufumi Sawada ; Koujirou Yamamoto ; Takashi Iikubo ; Hisakazu Ohtani ; Naoki Kamimura ; Yoshihiro Abe ; Keiko Uehara ; Takafumi Ohta ; Takao ORII ; Toshiko Kishimoto ; Mitsuo Saito ; Keiko Butatsu ; Hiroyuki Taruno ; Youhei Chikazawa ; Hiromitsu Nakasa ; Masayuki Hashiguchi ; Satoko HORI ; Toshinori Yamamoto
Japanese Journal of Drug Informatics 2009;11(2):76-87
In 2008, Japanese Society of Drug Informatics (JASDI) organized the Future Vision Committee (the Committee) to propose the essential focus of drug informatics. To explore a future vision about the drug information sciences, it was necessary to collect a variety of opinions widely from researchers. Therefore, at the 11th annual meeting of JASDI in July 5-6, 2008, the Committee convened a workshop to extract problems in the researches of drug informatics by using KJ method and evaluated the contents. The major problems raised were “the field of drug informatics is too broad” and “there is no definition and/or no system of the drug informatics”. Related problems raised are the shortness of the history and lack of originality in the study. From different viewpoints, it was also pointed out that the methodology of the research is not well established and no systematic education is provided. Taken together, major problems in drug informatics are concluded to be the lack of definition and the lack of systematizations, and will be solved to a certain extent by defining the outcome of the researches in drug informatics.
4.A Nationwide Survey on the Faculty Development for Simulation-Based Medical Education in Japan
Takashi SHIGA ; Kazsuhiko FUJISAKI ; Hiroyuki KOMATSU ; Takami MAENO ; Keiko ABE ; Junji HARUTA ; Yoshihiro TOCHINO ; Yasuhiko TAKEMOTO ; Kazunobu ISHIKAWA ; Taichi SHUTO
Medical Education 2019;50(3):245-250
We have conducted a nationwide survey on faculty development for simulation-based medical education in Japan. The response rate was 90%. Forty-seven (68%) schools have implemented faculty development programs for simulation-based education. The most commonly implemented contents were standardized patient development, task trainer, high fidelity manikin operation, and student evaluation, which were related to objective structured clinical examination objective clinical skill assessment. Only 15 percent of medical schools implemented topics on reflective practice, and scientific writing. A constraint on faculty time was the most commonly perceived barrier to simulation use (mentioned by 62 schools; 90%).